1. Prevalence of Neuropsychiatric Symptoms in Young-Onset Compared to Late-Onset Alzheimer's Disease - Part 1: Findings of the Two-Year Longitudinal NeedYD-Study.
- Author
-
Van Vliet, Deliane, De Vugt, Marjolein E., Aalten, Pauline, Bakker, Christian, Pijnenburg, Yolande A.l., Vernooij-Dassen, Myrra J.f.j., Koopmans, Raymond T.c.m., and Verhey, Frans R.j.
- Subjects
- *
AGE factors in disease , *ALZHEIMER'S disease , *ANALYSIS of variance , *ANXIETY , *CAREGIVERS , *CHI-squared test , *COMPARATIVE studies , *DELUSIONS , *MENTAL depression , *LONGITUDINAL method , *NEUROPSYCHOLOGICAL tests , *MOTIVATION (Psychology) , *NEUROLOGIC manifestations of general diseases , *PSYCHOMOTOR disorders , *RESEARCH funding , *T-test (Statistics) , *AGITATION (Psychology) , *SECONDARY analysis , *DISEASE incidence , *REPEATED measures design , *DISEASE prevalence , *DESCRIPTIVE statistics - Abstract
Background/Aims: Knowledge about neuropsychiatric symptoms in young-onset Alzheimer's disease (YO-AD) is scarce, but essential to establish a prognosis and plan care for YO-AD patients. The aim of this study is to assess frequency parameters of neuropsychiatric symptoms in YO-AD over 2 years and investigate whether there are differences compared with late-onset Alzheimer's disease (LO-AD). Methods: 98 YO-AD and 123 LO-AD patients and caregivers from two prospective cohort studies were included and assessed every 6 months for 2 years, using the Neuropsychiatric Inventory to evaluate neuropsychiatric symptoms. Results: Over the course of 2 years, the incidence, prevalence and persistence of neuropsychiatric symptoms were in general lower in YO-AD than in LO-AD, specifically for delusions, agitation, depression, anxiety, apathy, irritability and aberrant motor behavior. Frequency of individual symptoms showed large variability in both groups. Within the group of YO-AD patients, apathy was the most prevalent symptom. Conclusion: Neuropsychiatric symptoms, notably apathy, should be paid appropriate attention to in the diagnosis and treatment of YO-AD patients. Further research is needed to gain insight into the mechanisms underlying the differences in neuropsychiatric symptoms between YO-AD and LO-AD. Copyright © 2012 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF